~~<i id='45305F44DB'><strike id='45305F44DB'><tt id='45305F44DB'><pre id='45305F44DB'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

leisure time

author：fashion 2025-09-28 23:29:21 - browse：289

Elite athletes really are different from you and me. Or, at least their gut microbes are.

Scientists who analyzed stool samples of 15 runners a week before and after they competed in the 2015 Boston Marathon found unusually high levels of one particular microbe compared to 10 non-athletes. Levels of the microbe in question, Veillonella, spiked after an intense workout and bloomed even more after the marathon.

That was a lightbulb moment for the scientists because the bacterium is known for breaking down and eating lactate, a metabolite even ordinary runners equate with fatigue.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Prior authorization will have to move faster under new Biden rule

explore

hotspot

explore

entertainment

focus

hotspot

FormerNIHdirectorFrancisCollinsnowservesasWhiteHousescienceadviserMattRourke/APFormerNIHdirectorandc

WSS

Independent physicians launch a new lobbying group

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

A daunting task: navigating dual Medicare, Medicaid eligibility

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

How digital therapeutics firms are pivoting after Pear's bankruptcy

CRISPR pioneers react to Casgevy, first gene

hotspot

leisure time

explore

Medical records are filled with copy

U.K. considers world's first use of meningitis vaccine to address gonorrhea

The cancer drug shortage isn’t new — and neither are the solutions

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

The cancer drug shortage isn’t new — and neither are the solutions

Hospitals look to new technology to keep health care workers safe

George Santos makes 1st court appearance after pleading not guilty to 13 counts

NIH director takes cautious approach to Biden drug pricing priority

State Dept. review finds Biden bears some blame for Afghanistan failures

Weight loss drug costs may need more research, senator suggests

hotspot

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

Ransomware attacks on hospitals: Study outlines patient impact

AI generated plenty of interest at JPM but not a lot of trust

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

Prior authorization will have to move faster under new Biden rule

Does good food count as health care? Study aims to find out

explore

entertainment

focus

hotspot